The Psychiatric Neurosurgery Committee and Board of Directors of the American Society for Stereotactic and Functional Neurosurgery (ASSFN) would like to express their enthusiastic and unwavering commitment to research exploring the neuromodulatory treatment of psychiatric disease. The field has encountered recent challenges, with the discontinuation of two pivotal trials evaluating the efficacy of deep brain stimulation (DBS) for the treatment of depression. An unintended consequence of the discontinuation of these two trials is the interpretation by the public, industry, regulatory bodies, and health care professionals, that trial discontinuation represents a failure of the therapy, rather than just an unsuccessful trial. These perceptions may in turn result in a nihilistic approach to future therapeutic trials. Consequently, patients may despair that there is little hope for new successful treatments. In contrast, we continue to believe that there is great promise for the therapeutic application of neuromodulation to diseases of mood, behavior, and cognition. We wish to reassure the many sufferers of psychiatric disease that we are committed to untangling these complex disorders and remain steadfast in our conviction that neuromodulation will ultimately be an important therapeutic modality.
There is a natural inclination to interpret the closure of a trial as failure of a therapy. However, we must distinguish between the failure of a therapeutic strategy and an unsuccessful implementation of that particular strategy. The success of a trial is influenced by many variables, only some of which are inseparably tied to the fundamental treatment strategy. As such, the recent trial closures should prompt a committed examination of trial design rather than being viewed as a categorical indictment of the proposed therapy. To assume that the treatment itself has failed does not account for the many factors that influence success, within the very tight constraints of blinded, randomized studies. These include patient selection, disease variability, surgical technique, resolution of the
